As of December 2024, Nanjing Vazyme Biotech has a market cap of $1.30B. This makes Nanjing Vazyme Biotech the world's 6799th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $1.39B | -20.80% |
2023 | $1.76B | -28.46% |
2022 | $2.45B | -15.63% |
2021 | $2.91B | 11.92% |
2020 | $2.60B | 2.16% |
2019 | $2.54B | -1.84% |
2018 | $2.59B | 0.38% |
2017 | $2.58B | 36.08% |
2016 | $1.90B | -11.13% |
2015 | $2.14B | 60.92% |
2014 | $1.33B | -3.26% |
2013 | $1.37B | 18.89% |
2012 | $1.15B | - |